Type 2 & other diabetes

Cost‐effectiveness of the diabetes remission clinical trial ( DiRECT )/Counterweight‐Plus weight management programme, based on 5‐year follow‐up

Diabet MedPublished Cost-effectiveness analysis of the DiRECT randomised trial

Authors' conclusion

The costs involved in achieving remissions from type 2 diabetes with the Counterweight-Plus diet programme were offset within 5 years through reduced healthcare resource use. Though remission may ultimately relapse, sustained weight loss brings other longer term health gains. The intervention, even using one-to-one face-to-face contacts rather than remote delivery, which is increasingly adopted, generated both health gains and cost-savings compared with current best practice.

Study context

Population
Participants of DiRECT with T2D
Comparison
Counterweight-Plus weight management programme vs current best practice
Methodological detailslifetime horizon, 5-year follow-up data, modelling assumed relapse of all in remission after a maximum of 10 years
  • Lifetime horizon
  • 5-year follow-up data
  • Modelling assumed relapse of all in remission after a maximum of 10 years

Primary result

As reported in the abstract

Lifetime cost-effectiveness · lifetime horizon

Incremental QALYs with intervention

0.08

Saving per participant

£496

Further findings

Healthcare costs over 5 years

Total (discounted) healthcare cost-savings (excluding intervention costs) per participant
£2091
Healthcare costs per annum lower per participant in intervention arm (p < 0.05)
~£480
Total intervention cost per participant (95% CI: £1566, 1822)
£1691
Reduced hospital admissions accounted for the major part of the saving

Cost-savings and QALY gains over 5 years

Cost-savings
~£400
QALY gains
0.043
Remission associated with significant improvement in quality of life
  • Modelled

Original publication

Cost‐effectiveness of the diabetes remission clinical trial ( DiRECT )/Counterweight‐Plus weight management programme, based on 5‐year follow‐up. Diabet Med. Published 29 March 2026. doi:10.1111/dme.70306

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.